Blog

Dr. Neal Kassell, founder and chairman of the Foundation, recounts the lifesaving operations he performed on President Joe Biden’s aneurysms.

This two-day session will cover regulatory requirements for artificial intelligence (AI) and machine learning (ML) in medical devices and patent innovations implementing AI/ML technology in healthcare, including focused ultrasound equipment. The sessions will provide insights to both existing and aspiring equipment manufacturers who are considering using AI/ML in their devices, including best data management practices and tips for reducing the risk of bias. Signing up with the following registration link will provide access to both days. VIRTUAL EVENT Future of Healthcare: Navigating AI Integration in Medical Devices Tuesday, May 28, 202410:00 AM – 11:30 AM Eastern FDA regulatory needs for AI/ML in medical devices. Patent innovations for implementing AI/ML technology in healthcare. Wednesday, May 29, 202410:00 AM – 11:30 AM Eastern Complying with existing privacy regulations when training AI/ML models using patient data. Best data management practices for AI/ML, with an emphasis on reducing the risk of bias. REGISTER NOW Speakers Nathan EvansHead of Intellectual Property Practice GroupWoods Rogers Vandeventer Black Rick HamiltonChief Technology OfficerFocused Ultrasound Foundation Liz HeddlestonPrincipalWoods Rogers Vandeventer Black Mike Shumpert, MBAVice President, Data ScienceMosaic Data Science Bradley Merrill ThompsonAttorneyEpstein Becker & Green, P.C. Michael ZagorskiStrategic ConsultantEBG Advisors

SPIRE is a neuromodulation company developing therapeutic ultrasound for depression and chronic pain.

Results from two Phase 2 clinical trials support its effective and safe deployment in patients with treatment-resistant depression and chronic pain.